# SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) – FDA Inspection, Mar 15, 2024

Source: https://www.keypedia.com/records/fda_inspections/smithkline-beecham-pharma-gmbh-co-kg-dba-glaxosmithkline-biologicals/064ffa75-823f-4b4a-ac70-4da31c81faa0
Source feed: FDA_Inspections

> FDA inspection 1233707 of SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals), March 15, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1233707
- Company Name: SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals)
- Inspection Date: 2024-03-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1181891 - 2022-09-20
- [FDA Inspection 1101506 - 2019-07-05](https://www.keypedia.com/records/fda_inspections/smithkline-beecham-pharma-gmbh-co-kg-dba-glaxosmithkline-biologicals/63db143a-b785-4875-96d0-efc0ded378e0)
- [FDA Inspection 1019795 - 2017-06-27](https://www.keypedia.com/records/fda_inspections/smithkline-beecham-pharma-gmbh-co-kg-dba-glaxosmithkline-biologicals/e4847276-f3f0-4073-a7d2-e60f6d62c3c5)
- FDA Inspection 736162 - 2011-06-22
- FDA Inspection 668686 - 2010-05-24

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/thai-d-truong/7395c128-0adb-44a1-8831-64673c98e93d)
- [FDA Associated Person](https://www.keypedia.com/people/unnee-ranjan/43f1d07e-4079-4d33-88a9-baf6a5df932c)

Company: https://www.keypedia.com/companies/smithkline-beecham-pharma-gmbh-co-kg-dba-glaxosmithkline-biologicals/184bcdd6-8f25-45bf-b562-fcb41f6c48f7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d